Gene · 5603
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of four photodynamic therapy related genes inhibiting MAPK and inducing cell cycle alteration in squamous cell carcinoma. | Front Oncol | 2022 | 35992777 | PubTator, text mining | PubMed |
| Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders. | Chem Soc Rev | 2022 | 35983982 | PubTator, text mining | PubMed |
| MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase. | PLoS One | 2022 | 35980936 | PubTator, text mining | PubMed |
| A gene expression map of host immune response in human brucellosis. | Front Immunol | 2022 | 35979363 | PubTator, text mining | PubMed |
| Key Considerations in Targeted Protein Degradation Drug Discovery and Development. | Front Chem | 2022 | 35978859 | PubTator, text mining | PubMed |
| Resistance Evolution against Host-directed Antiviral Agents: Buffalopox Virus Switches to Use p38-ϒ under Long-term Selective Pressure of an Inhibitor Targeting p38-α. | Mol Biol Evol | 2022 | 35975687 | PubTator, text mining | PubMed |
| MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation. | Elife | 2022 | 35971771 | PubTator, text mining | PubMed |
| MIR133A regulates cell proliferation, migration, and apoptosis by targeting SOX9 in human colorectal cancer cells. | Am J Cancer Res | 2022 | 35968353 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| Autophagy related DNA methylation signature predict clinical prognosis and immune microenvironment in low-grade glioma. | Transl Cancer Res | 2022 | 35966301 | PubTator, text mining | PubMed |
| AMPK-related protein kinase ARK5 regulates subcellular localization of RNA-binding protein hnRNP A1 during hypertonic stress. | J Biol Chem | 2022 | 35963429 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis Reveals SH3TC2 as an Oncogene for Colorectal Cancer and Promotes Tumorigenesis via the MAPK Pathway. | Cancers (Basel) | 2022 | 35954399 | PubTator, text mining | PubMed |
| Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy. | Cells | 2022 | 35954167 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance. | Cell Rep | 2022 | 35947955 | PubTator, text mining | PubMed |
| Rapid and In-Depth Coverage of the (Phospho-)Proteome With Deep Libraries and Optimal Window Design for dia-PASEF. | Mol Cell Proteomics | 2022 | 35944843 | PubTator, text mining | PubMed |
| Therapeutic Target Analysis and Molecular Mechanism of Melatonin - Treated Leptin Resistance Induced Obesity: A Systematic Study of Network Pharmacology. | Front Endocrinol (Lausanne) | 2022 | 35937803 | PubTator, text mining | PubMed |
| Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions. | MedComm (2020) | 2022 | 35923762 | PubTator, text mining | PubMed |
| Role of the cystathionine β-synthase / H2S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome. | Redox Biol | 2022 | 35921774 | PubTator, text mining | PubMed |
| Network pharmacology for deciphering molecular mechanism of mahogany in dyslipidemia treatment of menopausal conditions. | Med J Malaysia | 2022 | 35899893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5603/papers?page=17